Farrant, JP, Schmitt, M, Reid, AB, Garratt, CJ, Newman, WG, Malhotra, A, Beynon, R, Mahmod, M, Raman, B, Cooper, RM, Dawson, D, Green, T, Prasad, SK, Singh, A, Dodd, S, Watkins, H, Neubauer, S and Miller, CA (2024) Considerations for drug trials in hypertrophic cardiomyopathy. ESC Heart Failure.

Farrant, J, Dodd, S, Vaughan, C, Reid, A, Schmitt, M, Garratt, C, Akhtar, M, Mahmod, M, Neubauer, S, Cooper, RM, Prasad, SK, Singh, A, Valkovič, L, Raman, B, Ashkir, Z, Clayton, D, Baroja, O, Duran, B, Spowart, C, Bedson, E et al, Naish, JH, Harrington, C, Miller, CA and TEMPEST investigators, (2023) Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society). ISSN 1355-6037